Results

Total Results: 4,870 records

Showing results for "treatment".

61. Death Inside Lemuel Shattuck Hospital: A Case Study on Medical Treatment for Persons with Mental Health Disabilities. | PSNet
    psnet.ahrq.gov/issue/death-inside-lemuel-shattuck-hospital-case-study-medical-treatment-persons-mental-health
    May 03, 2023 - Book/Report Death Inside Lemuel Shattuck Hospital: A Case Study on Medical Treatment … Citation Text: Death Inside Lemuel Shattuck Hospital: A Case Study on Medical Treatment for Persons … The analysis examines a delayed diagnosis, referral , and treatment of skin cancer that contributed … Citation Citation Text: Death Inside Lemuel Shattuck Hospital: A Case Study on Medical Treatment

62. Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic. | PSNet
    psnet.ahrq.gov/issue/recommendations-individualized-medical-treatment-and-common-adverse-events-management-lung
    March 24, 2019 - Commentary Recommendations of individualized medical treatment and common adverse … Recommendations of individualized medical treatment and common adverse events management for lung cancer … and other targeted therapies. … The authors also suggest approaches to managing treatment-related adverse events outside the hospital … August 19, 2020 Planning for a pandemic: mitigating risk to radiation therapy service

63. Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years. | PSNet
    psnet.ahrq.gov/issue/effect-rapid-response-system-patients-shock-time-treatment-and-mortality-during-5-years
    October 19, 2022 - Study Effect of a rapid response system for patients in shock on time to treatment … Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years … This study reported a reduced time to treatment for patients in shock, and a resulting decrease in mortality … Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years

64. Analysis of reported suicide safety events among veterans who received treatment through Department of Veterans Affairs-contracted community care. | PSNet
    psnet.ahrq.gov/issue/analysis-reported-suicide-safety-events-among-veterans-who-received-treatment-through
    August 21, 2019 - Study Analysis of reported suicide safety events among veterans who received treatment … Analysis of reported suicide safety events among veterans who received treatment through Department of … Patient Safety between January 2018 and June 2022, researchers found that deficiencies in mental health treatment … Analysis of reported suicide safety events among veterans who received treatment through Department of

65. Diagnostic discordance, uncertainty, and treatment ambiguity in community-acquired pneumonia: a national cohort study of 115 U.S. Veterans Affairs hospitals. | PSNet
    psnet.ahrq.gov/issue/diagnostic-discordance-uncertainty-and-treatment-ambiguity-community-acquired-pneumonia
    June 07, 2023 - Study Diagnostic discordance, uncertainty, and treatment ambiguity in community-acquired … Diagnostic discordance, uncertainty, and treatment ambiguity in community-acquired pneumonia: a national … An accurate diagnosis of pneumonia ensures that appropriate treatment can be administered in a timely … Diagnostic discordance, uncertainty, and treatment ambiguity in community-acquired pneumonia: a national

66. Heparin: improving treatment and reducing risk of harm. | PSNet
    psnet.ahrq.gov/issue/heparin-improving-treatment-and-reducing-risk-harm
    July 28, 2021 - Newspaper/Magazine Article Heparin: improving treatment and reducing risk of harm … Citation Text: Heparin: improving treatment and reducing risk of harm. … URL Cite Citation Citation Text: Heparin: improving treatment

67. Hearing on Patient Safety and Quality Issues in End Stage Renal Disease Treatment. | PSNet
    psnet.ahrq.gov/issue/hearing-patient-safety-and-quality-issues-end-stage-renal-disease-treatment
    December 23, 2012 - Testimony Hearing on Patient Safety and Quality Issues in End Stage Renal Disease Treatment … Citation Text: Hearing on Patient Safety and Quality Issues in End Stage Renal Disease Treatment. … This hearing focused on quality and safety of treatment for patients with end stage renal disease in … Citation Citation Text: Hearing on Patient Safety and Quality Issues in End Stage Renal Disease Treatment

68. Minimising treatment-associated risks in systemic cancer therapy. | PSNet
    psnet.ahrq.gov/issue/minimising-treatment-associated-risks-systemic-cancer-therapy
    December 22, 2021 - Review Minimising treatment-associated risks in systemic cancer therapy. … Minimising treatment-associated risks in systemic cancer therapy. … This article reviews the high-risk process of cancer drug therapy and describes how integrating pharmacist … Minimising treatment-associated risks in systemic cancer therapy. … March 1, 2023 Use of therapeutic outcomes monitoring method for performing of pharmaceutical

69. Training in safe opioid prescribing and treatment of opioid use disorder in internal medicine residencies: a national survey of program directors. | PSNet
    psnet.ahrq.gov/issue/training-safe-opioid-prescribing-and-treatment-opioid-use-disorder-internal-medicine
    March 17, 2021 - Study Training in safe opioid prescribing and treatment of opioid use disorder in … Training in safe opioid prescribing and treatment of opioid use disorder in internal medicine residencies … and how they provide instruction and experience to residents in safe opioid prescribing (SOP) and treatment … Training in safe opioid prescribing and treatment of opioid use disorder in internal medicine residencies … February 1, 2023 To expand the evidence base about harms from tests and treatments.

70. Physician understanding and ability to communicate harms and benefits of common medical treatments. | PSNet
    psnet.ahrq.gov/issue/physician-understanding-and-ability-communicate-harms-and-benefits-common-medical-treatments
    September 28, 2016 - Physician understanding and ability to communicate harms and benefits of common medical treatments … Physician Understanding and Ability to Communicate Harms and Benefits of Common Medical Treatments. … high quality care and requires that providers accurately communicate risks and benefits of potential treatment … interventions, their confidence in responses, use of statistical terminology when counseling patients on treatment … Physician Understanding and Ability to Communicate Harms and Benefits of Common Medical Treatments.

71. A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales. | PSNet
    psnet.ahrq.gov/issue/mixed-methods-analysis-patient-safety-incidents-involving-opioid-substitution-treatment
    August 25, 2021 - A mixed-methods analysis of patient safety incidents involving opioid substitution treatment … A mixed‐methods analysis of patient safety incidents involving opioid substitution treatment with methadone … 2,284 patient safety incident reports and found that harmful incidents involving opioid substitution treatment … A mixed‐methods analysis of patient safety incidents involving opioid substitution treatment with methadone

72. Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. | PSNet
    psnet.ahrq.gov/issue/antibiotic-resistant-infection-treatment-costs-have-doubled-2002-now-exceeding-2-billion
    July 02, 2019 - Study Classic Antibiotic-resistant infection treatment … Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually … increasingly common in hospitals and ambulatory care, primarily driven by overuse of antibiotics for treatment … Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually

73. Medication errors in the ambulatory treatment of pediatric attention deficit hyperactivity disorder. | PSNet
    psnet.ahrq.gov/issue/medication-errors-ambulatory-treatment-pediatric-attention-deficit-hyperactivity-disorder
    April 08, 2011 - Study Medication errors in the ambulatory treatment of pediatric attention deficit … Medication errors in the ambulatory treatment of pediatric attention deficit hyperactivity disorder. … study used MEDMARX data to characterize medication errors in the prescribing of medications for the treatment … Medication errors in the ambulatory treatment of pediatric attention deficit hyperactivity disorder.

74. Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children. | PSNet
    psnet.ahrq.gov/issue/measuring-inappropriate-medical-diagnosis-and-treatment-survey-data-case-adhd-among-school
    February 10, 2015 - Newspaper/Magazine Article Measuring inappropriate medical diagnosis and treatment … Measuring inappropriate medical diagnosis and treatment in survey data: The case of ADHD among school-age … attention deficit hyperactivity disorder, along with the consequences of misdiagnosis  and inappropriate treatment … Measuring inappropriate medical diagnosis and treatment in survey data: The case of ADHD among school-age

75. Association of adverse effects of medical treatment with mortality in the United States: a secondary analysis of the Global Burden of Diseases, Injuries, and Risk Factors study. | PSNet
    psnet.ahrq.gov/issue/association-adverse-effects-medical-treatment-mortality-united-states-secondary-analysis
    November 11, 2020 - Study Association of adverse effects of medical treatment with mortality in the United … Association of Adverse Effects of Medical Treatment With Mortality in the United States: A Secondary … researchers used data from 1990 through 2016 on mortality related to the adverse effects of medical treatment … Association of Adverse Effects of Medical Treatment With Mortality in the United States: A Secondary

76. Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms. | PSNet
    psnet.ahrq.gov/issue/alternatives-potentially-inappropriate-medications-use-e-prescribing-software-triggers-and
    February 18, 2011 - Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment … Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment … This study describes the development of improved alerts and alternate treatment algorithms to reduce … Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment

77. Microsoft PowerPoint - Spotlight Case_Delayed Diagnosis and Treatment of Lupus_SLIDES - FINAL.pptx (pdf file)
    psnet.ahrq.gov/sites/default/files/2024-03/delayed_diagnosis_and_treatment_of_sle.pdf
    January 01, 2024 - Microsoft PowerPoint - Spotlight Case_Delayed Diagnosis and Treatment of Lupus_SLIDES - FINAL.pptx … Spotlight Delayed Diagnosis and Treatment of Systemic Lupus Erythematosus with a Psychiatric Presentation … • The patient ultimately died of multiple organ failure. 7 DELAYED DIAGNOSIS AND TREATMENT OF … Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. … Neuropsychiatric lupus: new mechanistic insights and future treatment directions.

78. Effects of state opioid prescribing laws on use of opioid and other pain treatments among commercially insured U.S. adults. | PSNet
    psnet.ahrq.gov/issue/effects-state-opioid-prescribing-laws-use-opioid-and-other-pain-treatments-among-commercially
    October 13, 2018 - Study Effects of state opioid prescribing laws on use of opioid and other pain treatments … Effects of state opioid prescribing laws on use of opioid and other pain treatments among commercially … Effects of state opioid prescribing laws on use of opioid and other pain treatments among commercially … May 19, 2021 Training in safe opioid prescribing and treatment of opioid use disorder … October 13, 2018 Treatment patterns and clinical outcomes after the introduction of the

79. Geisinger’s Outpatient Addiction Medicine Specialty Program Uses Data-Driven Decision Making and MAT to Reduce Mortality Rates | PSNet
    psnet.ahrq.gov/innovation/geisingers-outpatient-addiction-medicine-specialty-program-uses-data-driven-decision
    October 30, 2024 - to develop an outpatient addiction medicine specialty program that incorporated medication-assisted treatment … However, inpatient treatment alone is often inadequate to address opioid addiction because of the chronic … Unfortunately, prior to implementation, the treatment culture in PA focused on an inpatient abstinence-only … model rather than integrating the use of medication-assisted treatment across all care settings. 3 … Treatment of substance use disorders is a relatively new field and a new specialty.

80. Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute coronary syndromes. | PSNet
    psnet.ahrq.gov/issue/excess-dosing-antiplatelet-and-antithrombin-agents-treatment-non-st-segment-elevation-acute
    November 10, 2015 - Study Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment … Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute … Treatment of acute coronary syndromes (ACS) benefits from extensive research outlining evidence-based … Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute … November 17, 2011 Relationship of incorrect dosing of fibrinolytic therapy and clinical